These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27857694)

  • 1. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
    Front Physiol; 2016; 7():516. PubMed ID: 27857694
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.
    Baqar S; Straznicky NE; Lambert G; Kong YW; Dixon JB; Jerums G; Ekinci EI; Lambert E
    BMJ Open Diabetes Res Care; 2019; 7(1):e000606. PubMed ID: 31114697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
    Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
    Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
    Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects.
    Straznicky NE; Eikelis N; Nestel PJ; Dixon JB; Dawood T; Grima MT; Sari CI; Schlaich MP; Esler MD; Tilbrook AJ; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):605-13. PubMed ID: 22090279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.
    Straznicky NE; Grima MT; Eikelis N; Nestel PJ; Dawood T; Schlaich MP; Chopra R; Masuo K; Esler MD; Sari CI; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E503-8. PubMed ID: 21177786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
    Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
    Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Markers in Older Women with a History of Gestational Diabetes and the Effects of Weight Loss.
    Ryan AS
    J Diabetes Res; 2018; 2018():5172091. PubMed ID: 29951553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.
    Grassi G; Seravalle G; Colombo M; Bolla G; Cattaneo BM; Cavagnini F; Mancia G
    Circulation; 1998 May; 97(20):2037-42. PubMed ID: 9610534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.
    Pontiroli AE; Pizzocri P; Librenti MC; Vedani P; Marchi M; Cucchi E; Orena C; Paganelli M; Giacomelli M; Ferla G; Folli F
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3555-61. PubMed ID: 12161474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].
    Qian C; Zhu C; Gao J; Bu L; Zhou D; Li N; Qu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):61-67. PubMed ID: 29354901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies.
    Lips MA; de Groot GH; De Kam M; Berends FJ; Wiezer R; Van Wagensveld BA; Swank DJ; Luijten A; Pijl H; Burggraaf J
    Eur J Endocrinol; 2013 Oct; 169(4):383-90. PubMed ID: 23847327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.
    Straznicky NE; Lambert EA; Nestel PJ; McGrane MT; Dawood T; Schlaich MP; Masuo K; Eikelis N; de Courten B; Mariani JA; Esler MD; Socratous F; Chopra R; Sari CI; Paul E; Lambert GW
    Diabetes; 2010 Jan; 59(1):71-9. PubMed ID: 19833893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deterioration of insulin release rate response to glucose during oral glucose tolerance test is associated with an increased risk of incident diabetes in normal glucose tolerance subjects.
    Li Y; He S; Sun Y; Li G; Xu Q; Wang C; Jia W
    IUBMB Life; 2017 Sep; 69(9):756-766. PubMed ID: 28762247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.